Clinical features and prognosis of patients with renal cancer and a second malignancy.
暂无分享,去创建一个
S. Calza | A. Antonelli | C. Simeone | N. Arrighi | D. Zani | S. Cunico | Serena Corti | T. Zanotelli | A. Cozzoli
[1] M. Colonna,et al. Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: a population-based study , 2009, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[2] M. Cooperberg,et al. Renal cell cancer stage migration , 2008, Cancer.
[3] R. Uzzo,et al. Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review. , 2008, The Journal of urology.
[4] J. Mclaughlin,et al. The epidemiology of renal cell carcinoma. , 2006, The Journal of urology.
[5] J. Cheville,et al. Second primary malignancies associated with renal cell carcinoma histological subtypes. , 2006, The Journal of urology.
[6] C. Beisland,et al. Multiple primary malignancies in patients with renal cell carcinoma: a national population‐based cohort study , 2006, BJU international.
[7] P. Horn-Ross,et al. Risk of second primary malignancies in women with papillary thyroid cancer. , 2006, American journal of epidemiology.
[8] F. Rabbani,et al. A population‐based study of renal cell carcinoma and prostate cancer in the same patients , 2006, BJU international.
[9] John D Boice,et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. , 2005, Journal of the National Cancer Institute.
[10] T. Koyanagi,et al. Multiple primary malignancies in Japanese patients with renal cell carcinoma , 2004, International journal of urology : official journal of the Japanese Urological Association.
[11] K. Czene,et al. Familial papillary renal cell tumors and subsequent cancers: a nationwide epidemiological study from Sweden. , 2003, The Journal of urology.
[12] K. Czene,et al. Kidney cancer in the Swedish Family Cancer Database: familial risks and second primary malignancies. , 2002, Kidney international.
[13] G. Plewig,et al. Risk of second primary malignancies in patients with cutaneous melanoma , 2001, The British journal of dermatology.
[14] P. Russo,et al. Second primary malignancies associated with renal cell carcinoma: influence of histologic type. , 2000, Urology.
[15] P. Russo,et al. Multiple primary malignancies in renal cell carcinoma. , 1998, The Journal of urology.
[16] L. Pusztai,et al. Coincident renal cell carcinoma and nonHodgkin's lymphoma: the M. D. Anderson experience and review of the literature. , 1998, The Journal of urology.
[17] K. Lamborn,et al. Second cancers following pediatric Hodgkin's disease. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] D. Hunter,et al. What causes cancer? , 1996, Scientific American.
[19] T. Tihan,et al. Coexistence of renal cell carcinoma and malignant lymphoma: A causal relationship or coincidental occurrence? , 1996, Cancer.
[20] C. Begg,et al. Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancers from the Surveillance, Epidemiology, and End Results (SEER) program. , 1995, American journal of epidemiology.
[21] H. Wegner. Multiple primary cancers in urologic patients. Audit of 19-year experience in Berlin and review of the literature. , 1992, Urology.
[22] Z. Braf,et al. Multiple primary malignant neoplasms in the genitourinary tract: occurrence and etiology. , 1989, The Journal of urology.
[23] J. Fraumeni,et al. Risk of second malignancy after cancers of the renal parenchyma, renal pelvis, and ureter , 1986, Cancer.
[24] A. Sciarra,et al. Multiple primary tumors: 17 cases of renal-cell carcinoma associated with primary tumors involving different steroid-hormone target tissues , 2005, World Journal of Urology.
[25] G. Eltabbakh,et al. Synchronous renal cell carcinoma and gynecologic malignancies. , 2003, Gynecologic oncology.
[26] F. di Silverio,et al. Renal cancer steroid receptors: biochemical basis for endocrine therapy. , 1979, European urology.